Title |
Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
|
---|---|
Published in |
PLOS ONE, February 2013
|
DOI | 10.1371/journal.pone.0055784 |
Pubmed ID | |
Authors |
Julian I. Borissoff, Jeroen J. T. Otten, Sylvia Heeneman, Peter Leenders, René van Oerle, Oliver Soehnlein, Sarah T. B. G. Loubele, Karly Hamulyák, Tilman M. Hackeng, Mat J. A. P. Daemen, Jay L. Degen, Hartmut Weiler, Charles T. Esmon, Joanne van Ryn, Erik A. L. Biessen, Henri M. H. Spronk, Hugo ten Cate |
Abstract |
Variations in the blood coagulation activity, determined genetically or by medication, may alter atherosclerotic plaque progression, by influencing pleiotropic effects of coagulation proteases. Published experimental studies have yielded contradictory findings on the role of hypercoagulability in atherogenesis. We therefore sought to address this matter by extensively investigating the in vivo significance of genetic alterations and pharmacologic inhibition of thrombin formation for the onset and progression of atherosclerosis, and plaque phenotype determination. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
United States | 1 | 2% |
Netherlands | 1 | 2% |
Unknown | 54 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 11 | 19% |
Researcher | 10 | 18% |
Student > Master | 8 | 14% |
Student > Bachelor | 7 | 12% |
Professor > Associate Professor | 5 | 9% |
Other | 8 | 14% |
Unknown | 8 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 17 | 30% |
Medicine and Dentistry | 15 | 26% |
Biochemistry, Genetics and Molecular Biology | 9 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Unspecified | 1 | 2% |
Other | 3 | 5% |
Unknown | 9 | 16% |